Exponent, Inc. — Form 10-K Summary
Reporting period: Fiscal year ended December 30, 2016 (52 weeks), compared primarily with the year ended January 1, 2016. The request metadata says “2015 Q4,” but the supplied filing is the 2016 Form 10-K.
Business context
Exponent provides multidisciplinary science and engineering consulting through two reportable segments: Engineering and Other Scientific, and Environmental and Health. Engagements are generally project-based, billed on a time-and-materials or fixed-price basis, and may be postponed or terminated by clients. Management cautions that backlog is small relative to annual revenue and is not a reliable predictor.
Financial performance and position
| Metric | FY 2016 | FY 2015 |
|---|---|---|
| Revenue | $315.1 million | $312.8 million |
| Revenue before reimbursements | $299.2 million | $295.7 million |
| Operating income | $61.9 million; 19.7% margin | $68.9 million; 22.0% margin |
| Net income | $47.5 million | $43.6 million |
| Diluted EPS | $1.75 | $1.60 |
| Operating cash flow | $66.9 million | $60.5 million |
| Cash, cash equivalents and short-term investments | $173.7 million | $171.6 million |
| Working capital | $193.8 million | $192.3 million |
- Revenue increased 0.7%; revenue before reimbursements rose 1.2%, primarily from higher billing rates, while billable hours declined about 0.6% and utilization fell from 72% to 70%.
- Operating income declined about 10.2% and operating margin contracted 2.3 percentage points. Compensation and related expenses rose 4.8%, faster than revenue.
- Net income and diluted EPS increased, but the comparison benefited from early adoption of ASU 2016-09: a $4.8 million excess stock-compensation tax benefit was recorded in income tax expense. Excluding that benefit, management reported net income of $42.7 million and diluted EPS of $1.57, with net income down 2% year over year.
- Engineering and Other Scientific revenue grew 4.3% to $248.3 million; Environmental and Health revenue declined 10.8% to $66.8 million. The latter was affected by the completion of a major project in 2015 and weaker oil-and-gas and industrial-chemicals demand.
- Investing cash outflow was $27.4 million, including $14.4 million of capital expenditures; financing cash outflow was $49.2 million, including $24.5 million of share repurchases and $18.8 million of dividends. The company bought adjacent Menlo Park warehouse property for $8.25 million.
- The filing reports no debt balance in the provided balance-sheet data. Long-term liabilities were $50.2 million, including $46.5 million of deferred compensation; operating lease commitments totaled $21.8 million.
Changes, outlook and risks
- Management cited strong demand in battery consulting and growth in materials and corrosion engineering, polymer science and materials chemistry, biomedical engineering, and human factors. Lower oil-and-gas spending and slower intellectual-property litigation offset some gains.
- Management expects compensation costs, other operating expenses, and general and administrative expenses to rise as it selectively hires, invests in infrastructure, expands business development and conducts staff initiatives. It gave no quantified revenue or earnings guidance.
- The company said existing cash and investments should cover working capital, capital spending, commitments, dividends, and repurchases for at least the next 12 months. It anticipated continued investment, dividends, repurchases, and possible complementary acquisitions, subject to available capital and Board approval.
- Key risks include uneven project timing and utilization, weak visibility from limited backlog, dependence on attracting and retaining skilled staff, competitive pricing, client concentration by industry, collection risk, and potential professional liability or reputational harm. Regulatory changes or tort reform could reduce demand for litigation-related work.
- International expansion brings foreign-exchange, regulatory, staffing and other execution risks; the company does not hedge foreign-currency exposure. Other disclosed matters include $1.956 million of unrecognized tax benefits, $8.607 million of goodwill, and potentially unlimited officer/director indemnification obligations, which management considers minimally exposed after insurance.
- The company adopted ASU 2016-09 early, affecting tax-benefit presentation and cash-flow classification. It expected adoption of the new revenue standard in fiscal 2018 to have no material impact; the lease standard, expected in fiscal 2019, was anticipated to materially increase reported assets and liabilities.
- The filing reports no material legal proceedings. The auditor gave an unqualified opinion on the financial statements and internal control over financial reporting; management also concluded controls were effective.
Most important facts for investors to verify
- Assess underlying earnings excluding the $4.8 million share-based-compensation tax benefit, and distinguish that accounting-driven uplift from operating performance.
- Track utilization, billable hours, hiring and compensation growth, especially whether the Environmental and Health segment stabilizes after the major-project completion.
- Evaluate whether Engineering segment growth can offset continued weakness in oil and gas, industrial chemicals, and litigation-related work.
- Review cash generation and capital returns against planned investment: FY 2016 included $24.5 million of repurchases and $18.6 million of dividends, with $57.3 million of repurchase authorization remaining.
- Monitor receivable quality and contract-loss allowances: net accounts receivable was $87.4 million and the allowance was $3.4 million at year-end.
- Confirm future lease-accounting effects, foreign-exchange exposure, deferred-compensation obligations, and the timing or resolution of unrecognized tax benefits.